Medisys hit by fresh delay in launch of safety syringe

Medisys, the Aberdeen-based medical devices group, has been hit by another delay to the launch of its revolutionary safety syringe and its marketing partner says it has "almost given up" on the product.

The Futura device has failed another set of last-minute safety tests conducted by Smiths Group, the FTSE 100 conglomerate that will distribute the product in the US. The revelation comes two months after Medisys said it had overcome design problems and that the product would be on the US market within a fortnight.

The string of delays has driven Smiths to despair, and its chief executive, Keith Butler-Wheelhouse, said he will not launch Futura until the problems have been comprehensively resolved. He said Smiths is no longer banking on the product making any sales at all. He said: "We cannot afford to put our reputation on the line for something that doesn't work correctly. We have almost given up on it, frankly".

The device, whose needle is pulled back inside the syringe with a rubber band to stop hospital staff pricking themselves, has been plagued by problems in development and manufacturing and last November even its launch was pulled at the last minute.

Tests by Smiths then had revealed defects which "in extreme circumstances, could affect its performance in certain clinical uses", but Medisys said it had successfully made the necessary improvements in July.

The latest tests to have thrown up problems are being conducted by staff at a number of US clinics.

Michael Barry, the finance director at Medisys, said that he did know of the data to which Mr Butler-Wheelhouse referred. The clinical process is still "incomplete", he said.

"In a clinical process there is a lot of data that has to be considered and collated and some comments have been positive, some negative. One of the comments we have had back is that the product needs in-service training," said Mr Barry.

A number of small UK companies have battled to design revolutionary syringes after the US - the world's biggest health market - introduced legislation to encourage the use of safer products so hospital workers are less likely to prick themselves. All have been plagued by delays. NMT abandoned the race entirely, saying it would try to sell its needleless syringe to drug companies, rather than direct to hospitals, while PowderJect Pharmaceuticals, recently sold to Chiron of the US, turned itself into a vaccines manufacturer.

Medisys shares were worth 166p in 2000, when the Futura syringe was supposedly just months away from launch. Yesterday, they were down 0.75p to 19.25p.

Start your day with The Independent, sign up for daily news emails
ebooks
ebooksAn introduction to the ground rules of British democracy
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
SPONSORED FEATURES
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Recruitment Genius: Sales Adviser - OTE £24,500

£22500 - £24500 per annum: Recruitment Genius: Inbound and outbound calls with...

Recruitment Genius: Business Development Executive / Sales - OTE £40,000

£18000 - £40000 per annum: Recruitment Genius: This fast growing Insurance Bro...

Guru Careers: Research Associate / Asset Management Research Analyst

£40 - 45k (DOE) + Benefits: Guru Careers: A Research Associate / Research Anal...

The Green Recruitment Company: Graduate Energy Analyst

£20000 Per Annum: The Green Recruitment Company: Summary: The Green Recruitm...

Day In a Page

Turkey's conflict with Kurdish guerrillas in Iraq can benefit Isis in Syria

Turkey's conflict with Kurdish guerrillas in Iraq can benefit Isis in Syria

Turkish President Erdogan could benefit politically from the targeting of the PKK, says Patrick Cockburn
Yvette Cooper: Our choice is years of Tory rule under Jeremy Corbyn or a return to a Labour government

Our choice is years of Tory rule under Corbyn or a return to a Labour government

Yvette Cooper urged Labour members to 'get serious' about the next general election rather than become 'a protest movement'
Singapore's domestic workers routinely exploited and often abused in the service of rich nationals

Singapore's hidden secret of domestic worker abuse

David Cameron was shown the country's shiniest veneer on his tour. What he didn't see was the army of foreign women who are routinely exploited and often abused in the service of rich nationals
Showdown by Shirley Jackson: A previously unpublished short story from the queen of American Gothic

Showdown, by Shirley Jackson

A previously unpublished short story from the queen of American Gothic
10 best DSLRs

Be sharp! 10 best DSLRs

Up your photography game with a versatile, powerful machine
Solved after 200 years: the mysterious deaths of 3,000 soldiers from Napoleon's army

Solved after 200 years

The mysterious deaths of 3,000 soldiers from Napoleon's army
Every regional power has betrayed the Kurds so Turkish bombing is no surprise

Robert Fisk on the Turkey conflict

Every regional power has betrayed the Kurds so Turkish bombing is no surprise
Investigation into wreck of unidentified submarine found off the coast of Sweden

Sunken sub

Investigation underway into wreck of an unidentified submarine found off the coast of Sweden
Instagram and Facebook have 'totally changed' the way people buy clothes

Age of the selfie

Instagram and Facebook have 'totally changed' the way people buy clothes
Not so square: How BBC's Bloomsbury saga is sexing up the period drama

Not so square

How Virginia Woolf saga is sexing up the BBC period drama
Rio Olympics 2016: The seven teenagers still carrying a torch for our Games hopes

Still carrying the torch

The seven teenagers given our Olympic hopes
The West likes to think that 'civilisation' will defeat Isis, but history suggests otherwise

The West likes to think that 'civilisation' will defeat Isis...

...but history suggests otherwise
The bald truth: How one author's thinning hair made him a Wayne Rooney sympathiser

The bald truth

How thinning hair made me a Wayne Rooney sympathiser
Froome wins second Tour de France after triumphant ride into Paris with Team Sky

Tour de France 2015

Froome rides into Paris to win historic second Tour
Fifteen years ago, Concorde crashed, and a dream died. Today, the desire to travel faster than the speed of sound is growing once again

A new beginning for supersonic flight?

Concorde's successors are in the works 15 years on from the Paris crash